Serum activin A and B levels predict outcome in patients with acute respiratory failure: a prospective cohort study

INTRODUCTION: 30 day mortality in patients with Acute Respiratory Failure (ARF) is approximately 30%, defined as patients requiring ventilator support for more than 6 hours. Novel biomarkers are needed to predict patient outcomes and to guide potential future therapies. The activins A and B, members...

Descripción completa

Detalles Bibliográficos
Autores principales: de Kretser, David Morritz, Bensley, Jonathan Guy, Pettilä, Ville, Linko, Rita, Hedger, Mark Peter, Hayward, Susan, Allan, Carolyn Anne, McLachlan, Robert Ian, Ludlow, Helen, Phillips, David James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4057391/
https://www.ncbi.nlm.nih.gov/pubmed/24172607
http://dx.doi.org/10.1186/cc13093

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4057391/
https://www.ncbi.nlm.nih.gov/pubmed/24172607
http://dx.doi.org/10.1186/cc13093

Ejemplares similares